Bright Minds Biosciences Inc. (DRUG) stock
DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
$20.76+0.25 (+1.22%)
Close on Nov 18, 2026Market cap $158.52MP/E –Yield –
Bright Minds Biosciences EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2024 it was -0.65 CAD. The highest annual figure on record is -0.65 CAD in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | -0.65 CAD | – |
| FY2023 | Sep 30, 2023 | -1.98 CAD | – |
| FY2022 | Sep 30, 2022 | -6.06 CAD | – |
| FY2021 | Sep 30, 2021 | -4.82 CAD | – |
| FY2020 | Sep 30, 2020 | -0.65 CAD | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?